{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-103160","form_type":"8-K","ticker":"TTRX","cik":"0002023016","company_name":"Turn Therapeutics Inc.","filed_at":"2025-10-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.348565+00:00","generated_at":"2026-05-17T02:01:43.673848+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Turn Therapeutics enters global supply and development pact with Medline for PermaFusion platform","bullets":["Turn grants Medline exclusive worldwide license to use Turn's 510(k) clearance for wound-care field-of-use.","Medline to lead global commercialization across 100+ countries; Turn provides formulation expertise, IP, and clinical development.","Initial term of three years with automatic one-year renewals; exclusivity subject to undisclosed volume thresholds.","Parties to collaborate on line extensions (foams, films, hydrogels, ointments, dressings) incorporating PermaFusion technology.","Public announcement required within 72 hours of October 23, 2025 effective date."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-103160","json":"https://secwatch.observer/filing/0001104659-25-103160.json","markdown":"https://secwatch.observer/filing/0001104659-25-103160.md","text":"https://secwatch.observer/filing/0001104659-25-103160.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2023016/000110465925103160/0001104659-25-103160-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2023016/000110465925103160/tm2529649d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T02:01:43.673848+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}